[RDHL] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
26-Jul-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -36.51%
YoY- -171.69%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 1,401 2,206 1,523 0 1 4 3 178.40%
PBT -9,835 -10,083 -15,512 -8,944 -3,292 -4,236 -2,699 24.03%
Tax 170 133 150 109 1,420 1,146 53 21.42%
NP -9,835 -10,083 -15,512 -8,944 -3,292 -4,236 -2,699 24.03%
Tax Rate - - - - - - - -
Total Cost 11,236 12,289 17,035 8,944 3,293 4,240 2,702 26.79%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -702.00 -457.07 -1,018.52 0.00 -329,200.00 -105,900.00 -89,966.67 -55.44%
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -13.87 -17.17 -36.14 -28.07 -10.74 -19.28 -17.24 -3.55%
EPS Diluted -13.87 -17.17 -36.14 -28.07 -10.66 -19.10 -17.24 -3.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.